All In Biotech

Drug Trial Radar · NCT02493452

Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)

Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Last checked: Nov 20, 2026Latest source record: Jun 14, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,135 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,135

Actual

Start

Jun 2015

Primary completion

Nov 2016

Study completion Feb 2017

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
First posted
Jul 9, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study in patients with IBS-C is a randomized, double-blind, placebo-controlled, parallel-group clinical trial with 12 weeks of study drug therapy.

Conditions

  • Irritable Bowel Syndrome Characterized by Constipation

Interventions

  • PlecanatideDrug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Overall Responders - ITT PopulationTime frame: 12 weeks
  2. Number of Abdominal Pain Responders for at Least 6 of 12 Treatment WeeksTime frame: 12 Weeks
  3. Number of Stool Frequency Responder for at Least 6 of the 12 Treatment WeeksTime frame: 12 Weeks

Locations

191 sites in 1 country. Site status is shown where the registry gives one.

  • Synergy Research Site

    Birmingham, Alabama

  • Synergy Research Site

    Birmingham, Alabama

  • Synergy Research Site

    Guntersville, Alabama

  • Synergy Research Site

    Huntsville, Alabama

  • Synergy Research Site

    Saraland, Alabama

  • Synergy Research Site

    Glendale, Arizona

  • Synergy Research Site

    Phoenix, Arizona

  • Synergy Research Site

    Surprise, Arizona

  • Synergy Research Site

    Tucson, Arizona

  • Synergy Research Site

    Conway, Arkansas

  • Synergy Research Site

    Little Rock, Arkansas

  • Synergy Research Site

    Canoga Park, California

  • Synergy Research Site

    Carmichael, California

  • Synergy Research Site

    Chino, California

  • Synergy Research Site

    Chula Vista, California

  • Synergy Research Site

    El Cajon, California

  • Synergy Research Site

    Encino, California

  • Synergy Research Site

    Foothill Ranch, California

  • Synergy Research Site

    Garden Grove, California

  • Synergy Research Site

    Huntington Beach, California

  • Synergy Research Site

    Irvine, California

  • Synergy Research Site

    Lomita, California

  • Synergy Research Site

    Long Beach, California

  • Synergy Research Site

    Los Angeles, California

  • Synergy Research Site

    Mission Hills, California

  • Synergy Research Site

    Montclair, California

  • Synergy Research Site

    Northridge, California

  • Synergy Research Site

    Norwalk, California

  • Synergy Research Site

    Oceanside, California

  • Synergy Research Site

    Orange, California

  • Synergy Research Site

    Orangevale, California

  • Synergy Research Site

    Placentia, California

  • Synergy Research Site

    Riverside, California

  • Synergy Research Site

    San Diego, California

  • Synergy Research Site

    San Marino, California

  • Synergy Research Site

    Santa Ana, California

  • Synergy Research Site

    Sherman Oaks, California

  • Synergy Research Site

    Colorado Springs, Colorado

  • Synergy Research Site

    Denver, Colorado

  • Synergy Research Site

    Hamden, Connecticut

Showing 40 of 191 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.